Senior insider sale
Chief Executive Officer at TRAVERE THERAPEUTICS, INC. — senior position signals high conviction
$18.20M
291.51K shares
What this filing means
DUBE ERIC M plans to sell 291.51K shares of TRAVERE THERAPEUTICS, INC. valued at approximately $18.20M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/16/2026ACC: 0001950047-26-009566
DirectorOfficer· Chief Executive Officer
Since Jan 2019
291.51K
Shares to sell
$18.20M
Approx. market value
195.84K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
9/16/2026
195.84KTotal acquired195.84K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/16/2026 | Exercise of Stock Options Cash | 195.84K | — |
| Total | 195.84K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
95.67K
Market value
$5.96M
9/15/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
195.84K
Market value
$12.24M
9/16/2026
Total
Units
291.51K
Value
$18.20M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/15/2026 | 95.67K | $5.96M | — | Completed |
| Planned — Approximate Date | ||||
9/16/2026 | 195.84K | $12.24M | NASDAQ | Planned |
| Total | 291.51K | $18.20M | ||